Clinical trial · Interventional
Different Level of ECSWT in Post Mastectomy Lymphedema
Different Levels of Energy of Extracorporeal Shock Wave Therapy in Post Masrectomy Lymphedema
NCT06278298CI-TRIAL-00074326unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
to investigate the effectiveness of different dosages of ECSW in the treatment of post mastectomy lymphedema volume and quality of life (Qol)
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphedema of Upper Limb | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CDT | Other | — | UNRESOLVED |
| Shockwave | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Group A
- description
- Shockwave
- interventionNames
- Device: Shockwave
- type
- EXPERIMENTAL
- label
- Group B
- description
- Shockwave
- interventionNames
- Device: Shockwave
- type
- PLACEBO_COMPARATOR
- label
- Group C
- description
- CDT
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 30 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: \- Criteria of selecting the patients from hospital included the following; 1. Their ages ranged from 30 to 50 years. 2. All patients were examined carefully by physician before the study procedure. 3. All patients were free from any other pathological conditions or histories of other health abnormalities except arm lymphedema. 4. They had undergone radical or modified radical mastectomy with axillary lymph node dissection with or without radiotherapy intervention. 5. Only ambulant subjects without any aides will be selected. 6. The degree of lymphedema in all subjects was grade 2 to 3 according to the classification of Foldi.(Foldi et al., 2006), (Appendix II ). 7. All patients will be medically stable. 8. Each patient will sign a consent form which in that insures her eligibility in the study. 9. All patients were treated by the same doctor and physiotherapist. Exclusion Criteria: * The subjects had been excluded from the study if they met one of the following criteria; 1. The patients had recurrent malignancy, active infection, and clinical evidence of obstructive venous diseases. 2. Patients contraindicated to ESWT due to bilateral, acute, and chronic inflammation as well as due to metastasis and poor skin condition were excluded. 3. The patients had neurological or orthopedic problems, and diabetes. 4. Patients with primary lymphedema. 5. Cardiopulmonary disease which decrease the patient activites.
References
Publications (0)
Data not yet available
No reference posted for this study.